SONTRAYA
DEAD

Serial Number

79344576

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SONTRAYA Trademark

Serial Number: 79344576 • Registration: 6959619

SONTRAYA is a trademark filed by NOVARTIS AG on May 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 18, 2022

Registration Date

January 24, 2023

Published for Opposition

November 8, 2022

Cancellation Date

November 11, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 9, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jun 9, 2025 DETH
NOTIFICATION PROCESSED BY IB
Apr 11, 2023 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 16, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 16, 2023 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 23, 2023 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 24, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2022 CNSA
ASSIGNED TO EXAMINER
Oct 3, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 12, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 12, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 12, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 12, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 12, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Jul 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 12, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 7, 2022 SDRC